Sheba Medical Center: Leukemia trials
The registry lists 10 Leukemia studies with Sheba Medical Center as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 7Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell MalignanciesRecruitingNCT07135466Phase 1/2
- Bisantrene Combination for Resistant AMLRecruitingNCT04989335Phase 2
- CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 ExpressionRecruitingNCT04257175Phase 2/3
- A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T CellsStatus unknownNCT04158011
- Bisantrene for Relapsed /Refractory AMLCompletedNCT03820908Phase 2
- Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous LeukemiaWithdrawnNCT02115672Phase 1/2
- TevaGastrim for Stem Cell Mobilization Sibling DonorsCompletedNCT01542944Phase 2
- Nilotinib Pre and Post Allogeneic Stem Cell TransplantationCompletedNCT00750659Phase 2
- Adipokines as Predictors of the Metabolic Syndrome in ALL SurvivorsStatus unknownNCT00566566
- Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old ChildrenCompletedNCT00552825